Australia's largest stock trading and investment forum Australia's #1 stock forum

ELE

Click for more information

0.00%

0.5¢ elmore ltd

Ann: Response to Price Query, page-69

First 69 Last

Share
Profile

Follow
mowibble

15,922 Posts.

468

04/09/14

12:48

Post #: 13923777
Share

Originally posted by mowibble ↑

it's just normal that when the shareprice breaks over the long term moving average, there's a pullback to test the breakout for support. it doesn't "have to" happen, nothing ever does, but it's a common expectation, and i think it's the reason why the bulk of buy orders didn't move up past 1.4 at any point today. i think that could suggest they are real buyers, waiting for a pullback. which would also mean that if the chart forms a higher low and they don't get filled, they may well move up for the next cycle.

that's the sort of process that leads to what i was referring to with the past chart. low price high liquidity stocks are great vehicles for traders to move in and out of at high rotation when the momentum stays. a company in transition is a great excuse for momentum. unlike exploration plays, the energy doesn't die once the results are out.

as far as penny's go, it could be a good place to be for a little while yet.

Expand

testing the 200ema properly for support now. if supply dries up here then it will be good for another profitable run over the next few days.

NSL Price at posting: 1.4¢ Sentiment: Buy Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

HotCopper Highlights: Your most watched and most discussed stocks this week

Trump is President Again: What Does This Mean for Crypto?

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

IMU

Imugene kicks off Australian trial for blood cancer treatment

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

First 69 Last

Add ELE (ASX) to my watchlist